Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000439719 | SCV000529266 | uncertain significance | not provided | 2023-03-08 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Ambry Genetics | RCV002328970 | SCV002628673 | uncertain significance | Inborn genetic diseases | 2021-02-11 | criteria provided, single submitter | clinical testing | The p.S1417T variant (also known as c.4249T>A), located in coding exon 39 of the KIF1A gene, results from a T to A substitution at nucleotide position 4249. The serine at codon 1417 is replaced by threonine, an amino acid with similar properties. This amino acid position is not well conserved in available vertebrate species, and threonine is the reference amino acid in other vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV002522361 | SCV003024698 | benign | Hereditary spastic paraplegia 30; Neuropathy, hereditary sensory, type 2C; Intellectual disability, autosomal dominant 9 | 2024-10-23 | criteria provided, single submitter | clinical testing |